Marjorie G. Zauderer, MD
Dr. Zauderer is a leading expert and researcher specializing in caring for people with thoracic cancers, including malignant pleural mesothelioma. As Professor of Medicine of Westchester Medical Center’s Division of Hematology and Neoplastic Diseases and Medicine in the Division of Oncology, she works with a multidisciplinary team of thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists, and interventional radiologists to identify the best possible treatment plan that honors her patients’ priorities and desired outcomes. Dr. Zauderer is working towards new therapies for the treatment of mesothelioma and other lung and chest cancers.[1]
Education and Career
Dr. Zauderer earned her medical degree at Columbia University’s College of Physicians and Surgeons. She then moved on to the New York-Presbyterian/Columbia University Medical Center where she completed her residency in Internal Medicine. She completed both a fellowship and chief fellowship in Hematology/Medical Oncology at Memorial Sloan Kettering Cancer Center and in Medicine at Weill Cornell Medical College. She is board certified in both Internal Medicine and Medical Oncology.
Before practicing at Westchester Medical Center, Dr. Zauderer was the co-director of Memorial Sloan Kettering’s Mesothelioma Program and an Associate Attending on the hospital’s Department of Medicine’s Thoracic Oncology Service. As a physician, she works to offer her patients personalized care in consultation with a multidisciplinary team and in keeping with the priorities of the individual and their family members and caregivers. She is also actively involved in research and is the principal investigator for numerous mesothelioma clinical trials.
Dr. Zauderer is a member of the NCI-CTEP Thoracic Malignancy Steering Committee Mesothelioma Working Group. She peer reviews Congressionally Directed Medical Research Programs sponsored by the Department of Defense and is active within the American Society of Clinical Oncology. She previously served on the Scientific Advisory Board for the Mesothelioma Applied Research Foundation and is now Chair of the organization’s Board of Directors.[2] She is a member of the Mesothelioma Committee of the International Association for the Study of Lung Cancer, and is a frequent lecturer on mesothelioma at both national and international conferences dedicated to finding a cure for the disease.
Research Interests
Dr. Zauderer is working to develop new therapies for mesothelioma and lung cancer. Much of her research is aimed at investigating inherited mutations in the BAP1 gene (BRCA-associated protein-1) that might predispose patients to malignant pleural mesothelioma and other cancers. She is also developing therapeutics for somatic BAP1 loss and other common molecular alterations, as well as novel immunotherapies and biomarkers that may predict response to these innovative treatments. Much of her work has been supported by the National Cancer Institute and the Department of Defense, as well as other sources of funding.
Dr. Zauderer’s personalized approach to mesothelioma care, her commitment to developing more effective therapies, and her work to place patients in appropriate clinical trials have made her one of the country’s leading mesothelioma physicians.
